CSL Ltd (CSLLY)
91.82
-0.54
(-0.58%)
USD |
OTCM |
May 08, 16:00
CSL Revenue (TTM): 14.04B for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 14.04B |
| June 30, 2023 | 13.17B |
| December 31, 2022 | 11.63B |
| June 30, 2022 | 10.49B |
| December 31, 2021 | 10.48B |
| June 30, 2021 | 10.27B |
| December 31, 2020 | 9.987B |
| June 30, 2020 | 9.100B |
| December 31, 2019 | 8.877B |
| June 30, 2019 | 8.510B |
| December 31, 2018 | 7.932B |
| June 30, 2018 | 7.588B |
| December 31, 2017 | 7.061B |
| June 30, 2017 | 6.616B |
| December 31, 2016 | 6.407B |
| June 30, 2016 | 5.910B |
| December 31, 2015 | 5.771B |
| June 30, 2015 | 5.459B |
| December 31, 2014 | 5.505B |
| June 30, 2014 | 5.335B |
| December 31, 2013 | 5.042B |
| June 30, 2013 | 4.950B |
| Date | Value |
|---|---|
| December 31, 2012 | 4.749B |
| June 30, 2012 | 4.537B |
| December 31, 2011 | 4.596B |
| June 30, 2011 | 4.476B |
| December 31, 2010 | 3.855B |
| June 30, 2010 | 3.787B |
| December 31, 2009 | 4.269B |
| June 30, 2009 | 3.730B |
| December 31, 2008 | 3.411B |
| June 30, 2008 | 3.403B |
| December 31, 2007 | 3.031B |
| June 30, 2007 | 2.691B |
| December 31, 2006 | 2.289B |
| June 30, 2006 | 2.114B |
| December 31, 2005 | 1.995B |
| June 30, 2005 | 2.097B |
| December 31, 2004 | 1.798B |
| June 30, 2004 | 1.157B |
| December 31, 2003 | 1.002B |
| June 30, 2003 | 877.98M |
| December 31, 2002 | 807.15M |
| June 30, 2002 | 752.40M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
8.510B
Minimum
Jun 2019
14.04B
Maximum
Dec 2023
10.65B
Average
10.37B
Median
Revenue (TTM) Benchmarks
| Alterity Therapeutics Ltd | -0.0416M |
| Kazia Therapeutics Ltd | -- |
| Immutep Ltd | 5.113M |
| Opthea Ltd | 0.1171M |
| Mesoblast Ltd | 7.501M |